Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): Evidence for cotransport with reduced glutathione

Cancer Research

Volumn 58, Issue 22, 1998, Pages 5130-5136

  Loe, Douglas W ^a   Deeley, Roger G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DAUNORUBICIN; DOXORUBICIN; GLUTATHIONE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN; VINCRISTINE;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL MEMBRANE TRANSPORT; COMPETITIVE INHIBITION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MEMBRANE VESICLE; MOLECULAR INTERACTION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; CELL MEMBRANE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; HELA CELLS; HUMANS; MOLECULAR WEIGHT; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0032534064     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Loe, D. W., Deeley, R. G., and Cole, S. P. C. Biology of drug resistance associated with overexpression of the multidrug resistance protein, MRP. Eur. J. Cancer, 32A: 945-957, 1996.
2. Deeley, R. G., and Cole, S. P. C. Function, evolution and structure of multidrug resistance protein (MRP). Semin. Cancer Biol., 8: 193-204, 1997.
3. Juranka, P. F., Zastawny, R. L., and Ling, V. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J., 3: 2583-2592, 1989.
4. Gottesman, M. M., Pastan, I., and Ambudkar, S. V. P-glycoprotein and multidrug resistance. Curr. Biol., 6: 610-617, 1996.
5. Slapak, C. A., Mizunuma, N., and Kufe, D. W. Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood, 84: 3113-3121, 1994.
6. Hasegawa, S., Abe, T., Naito, S., Kotoh, S., Kumazawa, J., Hipfner, D. R., Deeley, R. G., Cole, S. P. C., and Kuwano, M. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines. Br. J. Cancer, 71: 907-913, 1995.
7. Brock, I., Hipfner, D. R., Nielsen, B. E., Jensen, P. B., Deeley, R. G., Cole, S. P. C., and Sehested, M. Sequential coexpression of the multidrug resistance genes, MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res., 55: 459-462, 1995.
8. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C. Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
9. Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910, 1994.
10. Zhu, Q., Sun, H., and Center, M. S. Functional analysis of the nucleotide binding domains of the multidrug resistance protein (MRP). Oncol. Res., 9: 229-236, 1997.
11. Zaman, G. J. R., Flens, M. J., Van Leusden, M. R., de Haas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J., and Borst, P. The human multidrug resistance-associated protein MRP is a plasma membrane drus-efflux pump. Proc. Natl. Acad. Sci. USA, 91: 8822-8826, 1994.
12. Stride, B. D., Grant, C. E., Loe, D. W., Hipfner, D. R., Cole, S. P. C., and Deeley, R. G. Pharmacological characterization of the murine and human orthologs of multidrug resistance protein in transfected human embryonic kidney cells. Mol. Pharmacol., 52: 344-353, 1997.
13. Schlemmer, S. R., and Sirotnak, F. M. Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR3: properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport. J. Biol. Chem., 269: 31059-31066, 1994.
14. Cornwell, M. M., Pastan, I., and Gottesman, M. M. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J. Biol. Chem., 262: 2166-2170, 1987.
15. Sharom, F. J., Yu, X., and Doige, C. A. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem., 268: 24197-24202, 1993.
16. Muller, M., Meijer, C., Zaman, G. J. R., Borst, P., Scheper, R. J., Mulder, N. H., de Vries, E. G. E., and Jansen, P. L. M. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA, 91: 13033-13037, 1994.
17. 4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J. Biol. Chem., 271: 9675-9682, 1996.
18. Jedlitschky, G., Leier, I., Buchholz, U., Barnouin, K., Kurz, G., and Keppler, D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res., 56: 988-994, 1996.
19. Heijn, M., Hooijberg, J. H., Scheffer, G. L., Szabo, G., Westerhoff, H. V., and Lankelma, J. Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim. Biophys. Acta, 1326: 12-22, 1997.
20. Kruh, G. D. Corrections. Biochemistry, 36: 13972, 1997.
21. Paul, S., Breuninger, L. M., Tew, K. D., Shen, H., and Kruh, G. D. Correction. Proc. Natl. Acad. Sci. USA, 94: 14976, 1997.
22. McGrath, T., Latoud, C., Arnold, S. T., Safa, A. R., Felsted, R. L., and Center, M. S. Mechanisms of multidrug resistance in HL60 cells: analysis of resistance-associated membrane proteins and levels of mdr gene expression. Biochem. Pharmacol., 38: 3611-3619, 1989.
23. Keppler, D., Leier, I., and Jedlitschky, G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol. Chem., 378: 787-791, 1997.
24. Muller, M., de Vries, E. G. E., and Jansen, P. L. M. Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells. J. Hepatol., 24: 100-108, 1996.
25. 4 and structurally related conjugates. J. Biol. Chem., 269: 27807-27810, 1994.
26. 1 and its glutathione conjugates by the product of the MRP gene. Mol. Pharmacol., 51: 1034-1041, 1997.
27. Jedlitschky, G., Leier, I., Buchholz, U., Center, M., and Keppler, D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res., 54: 4833-4836, 1994.
28. Loe, D. W., Almquist, K. C., Cole, S. P. C., and Deeley, R. G. ATP-dependent 17β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein: inhibition by cholestatic steroids. J. Biol. Chem., 271: 9683-9689, 1996.
29. Evers, R., Cnubben, N. H. P., Wijnholds, J., van Deemter, L., van Bladeren, P. J., and Borst, P. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Lett., 419: 112-116, 1997.
30. Zaman, G. J. R., Cnubben, N. H. P., van Bladeren, P. J., Evers, R., and Borst, P. Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP. FEBS Lett., 391: 126-130, 1996.
31. Tew, K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res., 54: 4313-4320, 1994.
32. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res., 54: 5788-5792, 1994.
33. Mirski, S. E. L., Gerlach, J. H., and Cole, S. P. C. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res., 47: 2594-2598, 1987.
34. Cole, S. P. C., Pinkoski, M. J., Bhardwaj, G., and Deeley, R. G. Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br. J. Cancer, 65: 498-502, 1992.
35. 4 export carrier in mastocytoma cells. Eur. J. Biochem. 220: 599-606, 1994.
36. Smith, T. K., Ikeda, Y., Fujii, J., Taniguchi, N., and Meister, A. Different sites of acivicin binding and inactivation of γ-glutamyl transpeptidases. Proc. Natl. Acad. Sci. USA, 92: 2360-2364, 1995.
37. Hipfner, D. R., Almquist, K. C., Stride, B. D., Deeley, R. G., and Cole, S. P. C. Location of a protease-hypersensitive region in the Multidrug Resistance Protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. Cancer Res. 56: 3307-3314, 1996.
38. 4. J. Biol. Chem., 273: 10733-10740, 1998.
39. Leier, I., Jedlitschky, G., Buchholz, U., Center, M., Cole, S. P. C., Deeley, R. G., and Keppler, D. ATP-dependent glutathione disulfide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J., 314: 433-437, 1996.
40. Zaman, G. J. R., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P. J., Baas, F., and Borst, P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA, 92: 7690-7694, 1995.
41. Bender, R. A., Hamel, E., and Hande, K. R. Plant alkaloids. In: B. A. Chabner and J. M. Collins (eds.), Cancer Chemotherapy: Principles & Practice, pp. 253-275. Philadelphia: J. B. Lippincott Co., 1990.
42. Myers, C. E., and Chabner, B. A. Anthracyclines. In. B. A. Chabner and J. M. Collins (eds.), Cancer Chemotherapy: Principles & Practice, pp. 356-381. Philadelphia: J. B. Lippincott Company, 1990.
43. Lautier, D., Canitrot, Y., Deeley, R. G., and Cole, S. P. C. Multidrug resistance mediated by the Multidrug Resistance Protein (MRP) gene. Biochem. Pharmacol., 52: 967-977, 1996.
44. Versantvoort, C. H. M., Broxterman, H. J., Bagrij, T., Scheper, R. J., and Twentyman, P. R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br. J. Cancer, 72: 82-89, 1995.
45. Vanhoefer, U., Cao, S., Minderman, H., Toth, K., Skenderis, B. S., II, Slovak, M. L., and Rustum, Y. M. D,L-Buthionine-(S, R)-sulfoximine potentiates in rivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Clin. Cancer Res., 2: 1961-1968, 1996.
46. Schneider, E., Yamazaki, H., Sinha, B. K., and Cowan, K. H. Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. Br. J. Cancer, 71: 738-743, 1995.
47. Olsen, S. L., Leslie, E. M., Loe, D. W., Ooi, A. L-J., Deeley, R. G., and Cole, S. P. C. Site-directed mutagenesis of vicinal cysteine residues in human multidrug resistance protein. MRP. Proc. Amer. Assoc. Cancer Res., 39: 1145, 1998.
48. Taguchi, Y., Yoshida, A., Takada, Y., Komano, T., and Ueda, K. Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP). FEBS Lett., 401: 11-14, 1997.
49. Rappa, G., Lorico, A., Flavell, R. A., and Sartorelli, A. C. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of giutathione and natural product toxins. Cancer Res. 57:, 5232-5237, 1997.
50. Cole, S. P. C., Downes, H. F., Mirski, S. E. L., and Clements, D. J. Alterations in glutathione and glutathione-related enzymes in a multidrug resistant small cell lung cancer cell line. Mol. Pharmacol., 37: 192-197, 1990.